Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lenting

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|February 24, 1995
The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIIIM S Donath, P J Lenting, J A van Mourik, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2015
Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosisS Susen, A Rauch, E Van Belle, et al.
The Journal of Biological Chemistry|October 11, 1996
Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain bindingP J Lenting, O D Christophe, H Maat, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
Clearance of von Willebrand factorC Casari, P J Lenting, N Wohner, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
The von Willebrand factor self-association is modulated by a multiple domain interactionH Ulrichts, K Vanhoorelbeke, J P Girma, et al.
The Journal of Biological Chemistry|February 7, 1998
Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chainO D Christophe, P J Lenting, J A Kolkman, et al.
Journal of Thrombosis and Haemostasis : JTH|June 25, 2009
The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remissionE Groot, R Fijnheer, S A E Sebastian, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearanceN Wohner, P Legendre, C Casari, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Characterization of the interaction between von Willebrand factor and osteoprotegerinS Shahbazi, P J Lenting, C Fribourg, et al.
The Journal of Biological Chemistry|January 26, 1996
The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IXP J Lenting, J W van de Loo, M J Donath, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|February 24, 1995
The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIIIM S Donath, P J Lenting, J A van Mourik, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2015
Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosisS Susen, A Rauch, E Van Belle, et al.
The Journal of Biological Chemistry|October 11, 1996
Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain bindingP J Lenting, O D Christophe, H Maat, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
Clearance of von Willebrand factorC Casari, P J Lenting, N Wohner, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
The von Willebrand factor self-association is modulated by a multiple domain interactionH Ulrichts, K Vanhoorelbeke, J P Girma, et al.
The Journal of Biological Chemistry|February 7, 1998
Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chainO D Christophe, P J Lenting, J A Kolkman, et al.
Journal of Thrombosis and Haemostasis : JTH|June 25, 2009
The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remissionE Groot, R Fijnheer, S A E Sebastian, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearanceN Wohner, P Legendre, C Casari, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Characterization of the interaction between von Willebrand factor and osteoprotegerinS Shahbazi, P J Lenting, C Fribourg, et al.
The Journal of Biological Chemistry|January 26, 1996
The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IXP J Lenting, J W van de Loo, M J Donath, et al.
Pageof 4